<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yale J Biol Med</journal-id>
      <journal-id journal-id-type="pmc">yjbm</journal-id>
      <journal-id journal-id-type="publisher-id">YJBM</journal-id>
      <journal-title-group>
        <journal-title>The Yale Journal of Biology and Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0044-0086</issn>
      <issn pub-type="epub">1551-4056</issn>
      <publisher>
        <publisher-name>YJBM</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21966051</article-id>
      <article-id pub-id-type="pmc">3178863</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Relapse of Polymicrobial Endocarditis in an Intravenous Drug User</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang&#x2019;ondu</surname>
            <given-names>Ruth W.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Murray</surname>
            <given-names>Thomas S.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">b</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <aff id="A1"><label>a</label>Department of Cell Biology, Yale School of Medicine, New Haven, Connecticut</aff>
        <aff id="A2"><label>b</label>Department of Laboratory Medicine and Pediatrics, Yale School of Medicine, New Haven, Connecticut</aff>
      </contrib-group>
      <author-notes>
        <corresp id="COR1"><label>*</label>To whom all correspondence should be addressed: T.S. Murray, MD, PhD, Quinnipiac University Dept Basic Sciences, North Haven, CT; E-mail: <email>tscotmurray@gmail.com</email>, or Laboratory Medicine and Pediatrics, Yale School of Medicine, Room LSOG 420, New Haven, CT 06520; Tele: 203-785-4730; E-mail: <email>thomas.s.murray@yale.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <month>9</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2011</year>
      </pub-date>
      <volume>84</volume>
      <issue>3</issue>
      <fpage>321</fpage>
      <lpage>324</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9;2011, Yale Journal of Biology and
                    Medicine</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Yale Journal of Biology and Medicine</copyright-holder>
        <license license-type="open access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 26-year-old male intravenous drug user (IDU) presented twice within 6 months with relapsed polymicrobial infective endocarditis (IE) due to <italic>Eikenella corrodens</italic> and <italic>Streptococcus constellatus</italic> after completing two courses of appropriate antimicrobial therapy. This report points to relapsing endocarditis as a clinical entity that warrants attention in IDUs when <italic>E. corrodens</italic> or <italic>S. constellatus</italic> are causative agents of IE.</p>
      </abstract>
      <kwd-group>
        <kwd>relapse</kwd>
        <kwd>polymicrobial</kwd>
        <kwd>endocarditis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Intravenous drug users (IDUs) are at increased risk for infective endocarditis (IE) with tricuspid valve involvement caused by a variety of organisms, including <italic>Staphylococcus aureus</italic>, and both gram negative and/or gram positive oral flora [<xref ref-type="bibr" rid="R1">1</xref>]. The optimal treatment length for these patients is unknown, and some patients develop relapsing endocarditis despite appropriate antimicrobial therapy [<xref ref-type="bibr" rid="R2">2</xref>-<xref ref-type="bibr" rid="R4">4</xref>]. We report an instructive case of relapsing polymicrobial endocarditis in an IDU whose blood originally grew only <italic>S. aureus</italic> but later grew multiple fastidious organisms once the <italic>S. aureus</italic> had been treated. This case highlights: 1) the isolation of <italic>S. aureus</italic> does not preclude the presence of other organisms; 2) polymicrobial endocarditis is a risk for relapse, especially with <italic>E. corrodens</italic> and <italic>S. constellatus</italic>, even with prolonged antimicrobial therapy; 3) <italic>E. corrodens</italic> and <italic>S. constellatus</italic> are synergistic for infection in animal models, and this may be relevant for human infections as well; and 4) as urine toxicology screens do not necessarily rule out active drug use, the distinction between re-infection and relapse can be difficult.</p>
    </sec>
    <sec sec-type="discussion" id="s2">
      <title>Case Report</title>
      <p>A 26-year-old male presented to the emergency department with a 2-week history of fevers, chills, myalgias, non-productive cough, episodes of non-bloody emesis, and a 10- to 15-pound weight loss. He was a habitual IV heroine user until a few months prior to admission. He reported acquiring syringes from pharmacies to inject heroine mixed with tap water into both arms, denied licking the needle before injecting heroine, and denied reusing syringes. The patient admitted that he was on probation for 3 years for a drug-related misdemeanor committed a year before he presented. Conditions for his probation included out-patient drug rehabilitation, which he reported completing a few weeks before he presented, and periodic urine toxicology screens.</p>
      <p>On admission, the patent was afebrile. A 2/6 systolic murmur at the left lower sternal border (LLSB) was present on cardiac auscultation, but the lung fields were clear. No cutaneous abscesses, splinter hemorrhages, or Osler&#x2019;s nodes were appreciated. A urine toxicology screen was not obtained upon initial presentation. Lab results included white blood cell count 15, 100 cells/&#x3BC;L (82 percent neutrophils), positive recombinant immunoblot assay (RIBA) for hepatitis C virus (HCV), and an undetectable HCV viral load assayed by PCR. Hepatitis A, B, and HIV serologies were negative. A chest CT of the thorax showed bilateral scattered nodules, some of which were cavitating, later presumed to be septic emboli. A trans-esophageal echocardiogram demonstrated a mobile 0.8 x 0.8-cm density on the tricuspid valve with moderate tricuspid regurgitation and mild pulmonary hypertension. Blood cultures were drawn, and the patient was treated empirically for endocarditis with vancomycin and pipercillin/tazobactam.</p>
      <p>Four out of four blood culture sets obtained on the day of admission were positive for methicillin-sensitive <italic>S. aureus</italic>. Two out of four blood culture sets were positive for <italic>S. constellatus</italic> susceptible to clindamycin, penicillin (MIC of 0.094 &#xB5;g/ml), ceftriaxone, and vancomycin. The patient was given oxacillin (2 g every 4 hours) and gentamicin (80 mg every 8 hours), but his fevers persisted. Daily blood cultures over the next 14 days grew <italic>Prevotella intermedia, Eikenella corrodens</italic>, and <italic>Hemophilus parainfluenzae</italic> (<xref ref-type="fig" rid="F1">Figure 1</xref>). His antibiotic regimen was changed to ceftriaxone, metronidazole, and oxacillin. He improved and completed 6 weeks of antibiotic therapy administered by a home nursing service via a peripherally inserted central catheter (PICC). Blood cultures obtained 3 weeks after discharge were negative. However, blood cultures were not obtained after the patient completed the prescribed antibiotic regimen.</p>
      <p>The patient was readmitted 6 weeks after the completion of antibiotics with a palpable, non-tender, 2 x 2 inch mass in the right thigh, right hip pain that worsened with joint movement and weight bearing, malaise, fever, chills, night sweats, watery diarrhea, nausea, and vomiting. Blood cultures were again positive for <italic>E. corrodens</italic> and <italic>S. constellatus</italic>. Bilateral hip MRIs with and without intravenous contrast revealed a linear tear of the anterior-superior labrum in his right hip and a rim-enhancing fluid collection in the left obturator internus muscle that was sterile when an aspirate was cultured. A trans-esophageal echocardiogram revealed a 1.3 x 1.2 cm echodensity on the anterior leaflet of the tricuspid valve and an interval increase in degree of tricuspid regurgitation. A chest CT revealed almost complete resolution of the multiple pleura-based cavitary lesions. The patient reported that during the interval between his two hospitalizations, he had been subject to periodic urine toxicology screens that were negative for opiates. A urine toxicology screen performed when he presented was negative for cocaine, oxycodone, opiates, barbiturates, amphetamine, methadone, and phencyclidine and positive only for benzodiazepines. The patient was treated with gentamicin (80 mg every 8 hours) and ceftriaxone (2 g daily), improved, and was discharged to complete 2 weeks of gentamicin and 6 weeks of ceftriaxone administered by a home nursing service via a PICC. Cultures were negative after the patient completed his second course of antibiotics.</p>
      <p>He presented a third time 3 months later (<xref ref-type="fig" rid="F1">Figure 1</xref>) with a 7-day history of pleuritic chest pain, fevers, chills, and night sweats. A presumptive diagnosis of endocarditis was given, and he received vancomycin and pipercillin/tazobactam, later changed to vancomycin, ceftriaxone, and gentamicin. A chest CT was concerning for septic emboli, and a transthoracic echocardiogram showed his vegetation was unchanged from previous studies. Blood cultures on the day of presentation were positive for <italic>S. constellatus</italic> susceptible to penicillin, vancomycin, and ceftriaxone. On dental evaluation, poor oral hygiene was noted. A diagnosis of relapsing endocarditis was made, and the patient was given 4 weeks of penicillin G (3 million units every 4 hours) with 2 weeks of gentamicin (100 mg every 8 hours). The patient improved and was discharged but readmitted 10 days later with pleuritic right sided chest pain. A chest X-ray showed a new area of opacification in the right lower lobe. A CT scan of the chest showed multiple areas of ground glass opacification and consolidation involving the lower lobes, consistent with complicated pneumonia. The patient was treated with vancomycin and pipercillin/tazobactam, later switched to ampicillin/sulbactam. Blood cultures were positive only for <italic>Sphingomonas paucimobilis</italic>. The patient responded to therapy, discharged, and was not readmitted in the following 6 months.</p>
    </sec>
    <sec sec-type="discussion" id="s3">
      <title>Discussion</title>
      <p>A repeat episode of IE caused by the same species within 6 months of the initial episode is traditionally defined as a relapse, whereas a repeat episode 6 months after the initial episode is defined as recurrent IE or re-infection [<xref ref-type="bibr" rid="R3">3</xref>-<xref ref-type="bibr" rid="R6">6</xref>]. IDU is a known risk factor for recurrent or relapsing IE with incidences reported as high as 41 percent [<xref ref-type="bibr" rid="R3">3</xref>]. While in this case urine toxicology screens were negative, continued intermittent drug use cannot be conclusively eliminated as a cause of re-infection rather than relapse. Urine immunoassays detect &gt;300ng/ ml of 6-acetyl-morphine, typically picking up drug use within 54 hours, depending on dose of heroine. Active drug use should always be considered when evaluating patients for a repeat episode of IE [<xref ref-type="bibr" rid="R7">7</xref>]. IDUs are also at increased risk for polymicrobial IE with rates in one series of 8 percent [<xref ref-type="bibr" rid="R8">8</xref>]. While <italic>S. aureus</italic> is the most common cause of IE in IDUs, its presence does not rule out polymicrobial infection [<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R9">9</xref>]. This case illustrates how once the S. aureus is treated, more fastidious organisms can be recovered from the blood stream. <italic>Prevotella intermedia, Hemophilus parainfluenzae, S. constellatus</italic>, and <italic>E. corrodens</italic> are fastidious oral bacteria that cause IE in IDUs after salivary contamination of drug paraphernalia due to licking or blowing into needles or licking injection sites [<xref ref-type="bibr" rid="R10">10</xref>-<xref ref-type="bibr" rid="R14">14</xref>].</p>
      <p><italic>E. corrodens</italic> is often cultured with other bacteria and when recovered should alert the physician to the possibility of polymicrobial IE. <italic>S. constellatus</italic> and <italic>E. corrodens</italic> IE are enhanced by synergism between <italic>E. corrodens</italic> and streptococci hypothesized to be due to coinciding metabolic niches [<xref ref-type="bibr" rid="R15">15</xref>-<xref ref-type="bibr" rid="R17">17</xref>]. These organisms co-aggregate during <italic>in vitro</italic> growth, and 76 percent of <italic>S. anginosus</italic> group clinical isolates are recovered as part of a mixed culture. In animal models, infections result when <italic>E. corrodens</italic> is inoculated with streptococci, but not when <italic>E. corrodens</italic> is inoculated alone [<xref ref-type="bibr" rid="R15">15</xref>-<xref ref-type="bibr" rid="R17">17</xref>]. <italic>E. corrodens</italic> is also associated with clinical relapse as observed for this patient. <italic>S. constellatus</italic> blood stream infections are also a risk for embolic complications as observed in this case. This report demonstrates that physicians should be alert for relapse and embolic complications when <italic>E. corrodens</italic> and <italic>S. constellatus</italic> are isolated together during IE, even if past therapy was appropriate.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>This work is supported by NIH MSTP TG 2T32GM07205 to RW.</p>
    </ack>
    <glossary>
      <def-list>
        <def-item>
          <term>IDU</term>
          <def>
            <p>intravenous drug user</p>
          </def>
        </def-item>
        <def-item>
          <term>IE</term>
          <def>
            <p>infective endocarditis</p>
          </def>
        </def-item>
        <def-item>
          <term>LLSB</term>
          <def>
            <p>left lower sternal border</p>
          </def>
        </def-item>
        <def-item>
          <term>RIBA</term>
          <def>
            <p>recombinant immunoblot assay</p>
          </def>
        </def-item>
        <def-item>
          <term>HCV</term>
          <def>
            <p>hepatitis C virus</p>
          </def>
        </def-item>
        <def-item>
          <term>PICC</term>
          <def>
            <p>peripherally inserted central catheter</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="R1">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Brown</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>DP</given-names>
          </name>
          <article-title>Infective endocarditis in the injection drug user</article-title>
          <source>Infect Dis Clin North Am</source>
          <year>2002</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>645</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="pmid">12371120</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Carozza</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>De Santo</surname>
            <given-names>LS</given-names>
          </name>
          <name>
            <surname>Romano</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Della Corte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ursomando</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Scardone</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Infective endocarditis in intravenous drug abusers: Patterns of presentation and long-term outcomes of surgical treatment</article-title>
          <source>J Heart Valve Dis</source>
          <year>2006</year>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>125</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">16480024</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Welton</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Gentry</surname>
            <given-names>WO</given-names>
          </name>
          <article-title>Recurrent infective endocarditis. Analysis of predisposing factors and clinical features</article-title>
          <source>Am J Med</source>
          <year>1979</year>
          <volume>66</volume>
          <issue>6</issue>
          <fpage>932</fpage>
          <lpage>938</lpage>
          <pub-id pub-id-type="pmid">453226</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Levison</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Kaye</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mandell</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Hook</surname>
            <given-names>EW</given-names>
          </name>
          <article-title>Characteristics of patients with multiple episodes of bacterial endocarditis</article-title>
          <source>JAMA</source>
          <year>1970</year>
          <volume>211</volume>
          <issue>8</issue>
          <fpage>1355</fpage>
          <lpage>1357</lpage>
          <pub-id pub-id-type="pmid">4904718</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Baddour</surname>
            <given-names>LM</given-names>
          </name>
          <article-title>Twelve-year review of recurrent native-valve infective endocarditis: a disease of the modern antibiotic era</article-title>
          <source>Reviews of Infectious Diseases</source>
          <year>1988</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>1163</fpage>
          <lpage>1170</lpage>
          <pub-id pub-id-type="pmid">3060944</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Yung</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kottachchi</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Neupane</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Haider</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Loeb</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Antimicrobials for right-sided endocarditis in intravenous drug users: A systematic review</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2007</year>
          <volume>60</volume>
          <issue>5</issue>
          <fpage>921</fpage>
          <lpage>928</lpage>
          <pub-id pub-id-type="pmid">17881630</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Smith</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Shimomura</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Summers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Paul</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Darwin</surname>
            <given-names>DW</given-names>
          </name>
          <etal/>
          <article-title>Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin</article-title>
          <source>J Anal Toxicol</source>
          <year>2001</year>
          <volume>25</volume>
          <issue>7</issue>
          <fpage>504</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="pmid">11599592</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Levine</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Crane</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Zervos</surname>
            <given-names>MJ</given-names>
          </name>
          <article-title>Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study</article-title>
          <source>Reviews of Infectious Diseases</source>
          <year>1986</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>374</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="pmid">3755255</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Mathew</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Addai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Anand</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Morrobel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maheshwari</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Freels</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users</article-title>
          <source>Arch Intern Med</source>
          <year>1995</year>
          <volume>155</volume>
          <issue>15</issue>
          <fpage>1641</fpage>
          <lpage>1648</lpage>
          <pub-id pub-id-type="pmid">7618988</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Mah</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Shafran</surname>
            <given-names>SD</given-names>
          </name>
          <article-title>Polymicrobial endocarditis with eight pathogens in an intravenous drug abuser</article-title>
          <source>Scand J Infect Dis</source>
          <year>1990</year>
          <volume>22</volume>
          <issue>6</issue>
          <fpage>735</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="pmid">2284580</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Oh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Havlen</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Hussain</surname>
            <given-names>N</given-names>
          </name>
          <article-title>A case of polymicrobial endocarditis caused by anaerobic organisms in an injection drug user</article-title>
          <source>J Gen Intern Med</source>
          <year>2005</year>
          <volume>20</volume>
          <issue>10</issue>
          <fpage>958</fpage>
        </element-citation>
      </ref>
      <ref id="R12">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Silpa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>D&#x2019;Angelo</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Eikenella corrodens infections in drug abusers</article-title>
          <source>Ann Intern Med</source>
          <year>1980</year>
          <volume>92</volume>
          <issue>6</issue>
          <fpage>871</fpage>
          <pub-id pub-id-type="pmid">6992684</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Raucher</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dobkin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mandel</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Edberg</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Levi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Occult polymicrobial endocarditis with Haemophilus parainfluenzae in intravenous drug abusers</article-title>
          <source>Am J Med</source>
          <year>1989</year>
          <volume>86</volume>
          <issue>2</issue>
          <fpage>169</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">2913783</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Deutscher</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Perlman</surname>
            <given-names>DC</given-names>
          </name>
          <article-title>Why some injection drug users lick their needles: A preliminary survey</article-title>
          <source>International Journal of Drug Policy</source>
          <year>2008</year>
          <volume>19</volume>
          <issue>4</issue>
          <fpage>342</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="pmid">18638706</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Wanahita</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Goldsmith</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Musher</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Clarridge</surname>
            <given-names>JE</given-names>
            <suffix>3rd</suffix>
          </name>
          <name>
            <surname>Rubio</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Krishnan</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
          <article-title>Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria</article-title>
          <source>J Infect Dis</source>
          <year>2002</year>
          <volume>185</volume>
          <issue>1</issue>
          <fpage>85</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">11756985</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Young</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Allaker</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Hardie</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Whiley</surname>
            <given-names>RA</given-names>
          </name>
          <article-title>Interactions between Eikenella corrodens and &#x2018;Streptococcus milleri-group&#x2019; organisms: Possible mechanisms of pathogenicity in mixed infections</article-title>
          <source>Antonie van Leeuwenhoek</source>
          <year>1996</year>
          <volume>69</volume>
          <issue>4</issue>
          <fpage>371</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="pmid">8836435</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <element-citation publication-type="journal" publication-format="print">
          <name>
            <surname>Bottone</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Kittick</surname>
            <given-names>J</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Schneierson</surname>
            <given-names>SS</given-names>
          </name>
          <article-title>Isolation of bacillus HB-1 from human clinical sources</article-title>
          <source>Am J Clin Pathol</source>
          <year>1973</year>
          <volume>59</volume>
          <issue>4</issue>
          <fpage>560</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">4571277</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p><bold>Summary of microbes in patient&#x2019;s blood and course of antibiotic therapy.</bold> The specific microorganisms isolated from the patient&#x2019;s blood cultures and antibiotics during each of his four hospitalizations denoted by Roman numerals I-IV are shown. The number of hours to positivity for each organism isolated from each blood culture is indicated on the top part of the cell. The number of bottles positive out of all bottles is shown on the bottom part of the cell.</p>
      </caption>
      <graphic xlink:href="yjbm_84_3_321_g01"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
